Pulmonary complications with the use of mTOR inhibitors in targeted cancer therapy: a systematic review and meta-analysis. (Record no. 22916729)

MARC details
000 -LEADER
fixed length control field 01446 a2200385 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250516161043.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201505s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1776-260X
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1007/s11523-013-0289-2
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Gartrell, Benjamin A
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20150527
245 00 - TITLE STATEMENT
Title Pulmonary complications with the use of mTOR inhibitors in targeted cancer therapy: a systematic review and meta-analysis.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Targeted oncology
Date of publication, distribution, etc. Sep 2014
300 ## - PHYSICAL DESCRIPTION
Extent 195-204 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Meta-Analysis; Review; Systematic Review
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Lung
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Lung Diseases
General subdivision chemically induced
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Molecular Targeted Therapy
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Neoplasms
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Protein Kinase Inhibitors
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Randomized Controlled Trials as Topic
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element TOR Serine-Threonine Kinases
General subdivision antagonists & inhibitors
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ying, Jian
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Sivendran, Shanthi
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Boucher, Kenneth M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Choueiri, Toni K
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Sonpavde, Guru
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Oh, William K
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Agarwal, Neeraj
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Galsky, Matthew D
773 0# - HOST ITEM ENTRY
Title Targeted oncology
Related parts vol. 9
-- no. 3
-- p. 195-204
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1007/s11523-013-0289-2">https://doi.org/10.1007/s11523-013-0289-2</a>
Public note Available from publisher's website

No items available.